Quantamental Technologies’s GSK GSK Stock Holding History

Quantamental Technologies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,026	Closed	-$1.13M	–	498
2022 Q4	$1.13M	Buy	+32,026	New	+$1.07M	0.51%	39
2022 Q3	–	Sell	-10,978	Closed	-$597K	–	565
2022 Q2	$597K	Buy	10,978 +5,230	+91%	+$289K	0.27%	132
2022 Q1	$313K	Buy	+5,748	New	+$312K	0.18%	227
2019 Q1	–	Sell	-4,080	Closed	-$195K	–	1599
2018 Q4	$195K	Buy	+4,080	New	+$201K	0.12%	297

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantamental Technologies's GSK Position: Q1 2023 in Review

Quantamental Technologies sold out of GSK (GSK) in Q1 2023, closing a stake of 32,026 shares — an estimated $1.13M sold.

Quantamental Technologies first reported a position in GSK in Q4 2018 and held it in 4 quarters. The position peaked at $1.13M in Q4 2022. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Quantamental Technologies reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Quantamental Technologies sold 32,026 GSK shares in Q1 2023, an estimated $1.13M.
Quantamental Technologies first reported a position in GSK in Q4 2018 and held it in 4 quarters.
Quantamental Technologies's GSK position peaked at $1.13M in Q4 2022.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.